Quantumdx Group

Point-of-care molecular diagnostic platforms and assays for clinicians and healthcare providers

Newcastle Upon Tyne, United KingdomFounded 2008quantumdx.com Website technologies

Highlights

New on EvolcAdded 2026-10-29

About Quantumdx Group

QuantuMDx develops multiplex molecular diagnostic platforms and assays for point-of-care testing. Its products include the Q-POC system and assays for respiratory infections, sexually transmitted infections and antimicrobial resistance.

The company is headquartered in Newcastle upon Tyne, UK. It also works with partners to develop diagnostic applications in areas including pharmacogenetics, forensics, environmental monitoring and veterinary medicine.

Product: Point-of-care molecular diagnostic platforms and multiplex assays, including the Q-POC system.

Jobs at Quantumdx Group

No open positions listed right now.

Leadership

John Burn · Founding Chair
Source: company website
Martin Walton · CEO - Chief Executive Officer
Source: company website
Xu Fan · CEO (Quinten) - Chief Executive Officer
Source: company website
Jonathan O’Halloran · CTO - Chief Technical Officer
Source: company website

More biotech & pharma companies

Reach Separations
Chromatography analysis and purification services for pharmaceutical, agrochemical and fine chemical companies
Nottingham, United KingdomBiotech & pharmaFounded 20111 open job
New on EvolcSalary transparent
Redx Pharma
Clinical-stage biotech developing small-molecule anti-fibrotic drugs, led by a ROCK inhibitor for Crohn's disease
Macclesfield, United KingdomBiotech & pharmaFounded 20101 open job
New on Evolc
Refeyn
Mass photometry instruments and consumables for protein, antibody and viral vector analysis in research and biopharma labs
Oxford, United KingdomBiotech & pharmaFounded 20184 open jobs
Salary transparent
relationrx
AI-enabled drug discovery and development for pharmaceutical partners and patients
Regent’s Place, United KingdomBiotech & pharma11 open jobs
Relonchem
Develops and supplies own-label generic medicines for healthcare customers in the UK and international markets
Widnes, United KingdomBiotech & pharmaFounded 2003
New on Evolc
Renaissance Pharma
Develops an investigational anti-GD2 antibody immunotherapy for children with high-risk neuroblastoma
Surrey, United KingdomBiotech & pharmaFounded 2022
Young companyNew on Evolc